Correspondence. Circulating Immune Complexes in Primary Sclerosing Cholangitis
Anastasios A. Mihas, John E. Volanakis, Ralph E. Schrohenloher, Tony A. Mihas, Henry C. Bodenheimer, Nicholas F. Larusso, Walter R. Thayer, Colette Charland, Parker J. Staples, Jurgen Ludwig, M. Roggendorf, F. Deinhardt, Gert G. FrÖSner – 1 March 1984
Ultrastructural Studies of Fibroblasts Transfected with Hepatitis B Virus DNA
Naoto Aoki, Michael A. Gerber, Swan N. Thung, Mei‐Ling Chen, Judith K. Christman, Peter M. Price, Christos S. Flordellis, George Acs – 1 January 1984 – Cultured 3T3 mouse fibroblasts transfected with cloned hepatitis B virus genome and DNA coding for methotrexate‐resistant dihydrofolate reductase, produce and secrete significant amounts of hepatitis B surface antigen (HBsAg).
When Is Vitamin D‐Responsive Bone Disease Not Osteomalacia?
Irwin H. Rosenberg – 1 January 1984
Chronic Active Liver Disease. Edited by Sidney Cohen and Roger D. Soloway. ix + 266 pp. Illustrated. New York: Churchill Livingstone, 1983. $36
Charles S. Davidson, Raymond S. Koff – 1 January 1984
Alcoholic Liver Disease: Evaluation of Natural History and Prognostic Factors
Steven Schenker – 1 January 1984
Medical Treatment Vs. Transplantation in Liver Disorders
Steven Schenker – 1 January 1984
Fluidity and Function of Hepatocyte Plasma Membranes
David Schachter – 1 January 1984
Human Liver Transplantation: Analysis of Data on 540 Patients from Four Centers
Bruce F. Scharschmidt – 1 January 1984 – The results of liver transplantation in a total of 540 patients from four centers in the United States and Western Europe have been collated. Twenty‐five per cent of all transplants were performed for neoplastic disease. One– and 3–year survivals for this group were approximately 26 and 12% overall, and survival differed little for patients transplanted before and after January 1, 1980. Among the 44% of patients transplanted for endstage cirrhosis, 3–year survival was lowest for patients with alcoholic cirrhosis (20%).
The Influence of Vasoactive Agents on Metabolic Activity of the Liver in Cirrhosis: A Study of the Effects of Posterior Pituitary Extract, Vasopressin, and Somatostatin
Jean‐Claude Barbare, Raoul Poupon, Patrice Jaillon, Philippe Bories, Michele Aussanaire, François Darnis, Henri Michel, Georges Cheymol – 1 January 1984 – We studied the influence of posterior pituitary extract, vasopressin, and somatostatin on hepatic elimination function. Hepatic clearance and its two biological determinants, hepatic blood flow and metabolic activity (clearance Vmax/Km), were determined from hepatic indocyanine green elimination at steady‐state in cirrhotic patients.